R3
Mountain View, CA
R3 Vascular creates bioresorbable scaffold technology with a sirolimus coating for the treatment of peripheral arterial disease. R3 Vascular's polymer and proprietary technologies are used to create scaffolds that balance strength and flexibility for the treatment of peripheral arterial disease. The magnitude BRS device is the thinnest BRS ever tested in this clinical setting, with a strut thickness of 98 microns across its entire usable range of diameters.
r3vascular.comCompany Details
Founded
- 2019
Employees
- Between 10 - 50 employees
Raised
- $104,800,000
Headquarters Location
- Mountain View, CA
Public
- No
Acquired
- No
CEO
- Kamal Ramzipoor
Company Collections
These are collections R3 is a part of. Click on the collection name to view similar companies.